Blood Platelets Market Size & Share, by Application (Platelet Function Disorder, Hemophilia, Thrombocytopenia, Perioperative Indication); Platelets (Whole Blood Derived Platelets, Apheresis Derived Platelets); End-user (Hospitals, Ambulatory Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4719
  • Published Date: Jul 14, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023 - 2035

Blood Platelets Market size is predicted to reach USD 8 billion by the end of 2035, rising at a CAGR of 4% over the forecast period i.e., 2023 - 2035. In the year 2022, the industry size of blood platelets was around USD 5.2 billion. The growth of this market is primarily driven by the increasing awareness about the importance of blood donation and the need for platelets has led to an increase in voluntary blood donations. The government, healthcare firms, and non-profit organizations across the globe are carrying out several initiatives to encourage blood and platelet donations.

Moreover, the increasing demand for blood transfusion is giving rise to the global blood platelets market growth. The blood transfusion demand has been significantly growing on account of growing acceptance by the US FDA regarding blood transfusion products consisting of blood platelets and advanced technologies aiding blood donation and storage. The blood to be transfused is first analyzed with the help of blood transfusion diagnostics.


Blood Platelets Market
Get more information on this report: Request Free Sample PDF

Blood Platelets Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Geriatric Population – The aging population is more prone to conditions requiring platelet transfusion such as cancer, cardiovascular disease, and chronic liver disease. As the global population ages, the demand for blood platelets is anticipated to grow due to the high prevalence of age-related health issues.
  • Growing Prevalence of Blood-Related Disorder - With the growing prevalence of chronic blood disorders such as hemophilia, myelofibrosis, and thrombocytopenia, the demand for platelets is growing. As these conditions demand regular platelet transfusion to manage bleeding episodes. Around 324,648 out of 5.5 billion people worldwide have an identified bleeding disorder, reported as by the World Federation of Hemophilia's 2019 annual global survey. 
  • Surge in Number of Surgical Procedures - The increasing number of surgical procedures worldwide also contributes to the increased need for blood platelets. The increase in orthopedic and cardiac surgeries has increased the need for platelets in hospitals. In addition, increased organ transplantation such as kidney, corneal implants, and others has increased the demand for platelets. Recorded by World Observatory on Donations and Transplants, 153,863 organs were transplanted annually in 2019, which is an increase of 4.8% from 2018. 

Challenges

  • High Risk Related to the Transmission of Infections - Blood transfusions comprise significant health risks. Among these, transmission of infectious organisms remains one of the most concerning complications. Hepatitis B used to be the biggest transfusion risk. Also, there may be a chance of wrong blood group typing while transferring the blood to the patients. However, unnecessary blood transfusions should be avoided to reduce the risk of infection and other complications.  
  • High Treatment Cost Associated
  • Shortage of Blood Donors

Blood Platelets Market: Key Insights

Base Year

2022

Forecast Year

2023 – 2035

CAGR

~4%

Base Year Market Size

~USD 5.2 billion

Forecast Year Market Size

~USD 8 billion

Regional Synopsis

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Blood Platelets Segmentation 

Application (Platelet Function Disorder, Hemophilia, Thrombocytopenia, Perioperative Indication)

The platelet function disorder segment is assumed to dominate the blood platelets market with a revenue of 51% by the end of 2035. The growth of this market is majorly driven by the growing prevalence of cancer among the population. Chronic myelogenous leukemia and various myeloma cancers result in the development of acquired platelet dysfunction in some cancer patients. Therefore, cancer patients often have to receive platelet transfusions. In addition, chronic platelet dysfunction increases the need for platelet transfusions. The incidence of myeloma in the UK is projected to increase by 11% between 2014 and 2035, reported as by Cancer Research UK Statistics 2021. These figures indicate an increasing demand for platelet transfusions in the treatment of cancer patients. Therefore, platelets are often given to such patients to reduce the need for red blood cells, surgical blood loss, and complications such as reoperation due to bleeding. 

End Users (Hospitals, Ambulatory Surgical Centers)

The hospital segment is predicted to witness the largest share of 72% during the time period between 2023 – 2035. The expansion of the segment can be attributed on the back of the accessibility of talented experts in the hospitals. The blood platelets market is expanding as a result of an increase in hospital admissions for patients with cancer, hemophilia, and other severe platelet disorders. Furthermore, higher accessibility of blood parts in hospitals brings about expanded use of blood platelets, bringing about expanded reception. Also, blood platelets are in high demand in hospitals as a result of an increase in the number of surgeries and severe injuries that necessitate blood transfusions. Additionally, promotive reimbursement policies have resulted in high demand for blood platelets in the hospital segment.

Our in-depth analysis of the global market includes the following segments:

           Application

  • Platelet Function Disorder
  • Hemophilia
  • Thrombocytopenia
  • Perioperative Indication

           Platelets

  • Whole Blood Derived Platelets
  • Apheresis Derived Platelets

           End User

  • Hospitals
  • Ambulatory Surgical Centers

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Blood Platelets Industry – Regional Synopsis

North American Market Forecast

The blood platelets market in the North America region is predicted to dominate the market with a share of 35 % during the time period between 2023 – 2035. The growth of the market in this region is primarily driven by the increased demand for blood transfusion, followed by the rising number of accidents. As per the U.S. Department of Transportation, the number of people who died in motor vehicle traffic crashes increased to 9,560 in the first quarter of 2022. Furthermore, in the North America region, several countries have been experiencing economic growth which is expected to contribute to the increased healthcare spending and demand for advanced medical treatments.

APAC Market Statistics

The Asia Pacific region market for blood platelets is estimated to experience significant market expansion with a revenue of 28 percent by the end of the predicted period. The growth of this sector is driven on the back of several factors such as a high number of the presence of bleeding disorder, especially in emerging economies such as India and China. Besides, the growing number of trauma cases and advancement in healthcare infrastructure in the region are raising awareness related to blood donation in the Asia Pacific region. Blood donation in China grew by more than 40 percent between 1998 and 2020 due to growing awareness.

Research Nester
Blood Platelets Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Blood Platelets Landscape

top-features-companies
    • Aggredyne Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Sysmex Corporation
    • Haemochrom Diagnostics GmbH
    • Eurobio Scientific
    • LABiTec Labor BioMedical Technologies GmbH
    • Thermo Fisher Scientific Inc.
    • PerkinElimer Inc.
    • Werfen, S.A.
    • F. Hoffmann-La Roche Ltd.
    • Terumo Corporation

In-the-news

In The News

  • Aggredyne, Inc. announced the AND Drug Administration approval for its AggreGuide A-100 ADP Assay testing cartridge, an in vitro diagnostic tool. It is used to assess the effects of antiplatelet drugs that target the platelet P2Y12 receptor. The clearance enables the company to market products across the United States and broadens the range of additional tests that may be performed using the A-100 equipment. 
  • Terumo Blood and Cell Technologies officially launched MUGARD WB Platelet Pooling Set after receiving clearance from U.S. Food and Drug Administration clearance. It is the first platelet pooling set in the US to receive approval for seven-day storage and can be really helpful at times platelet storage. 

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4719
  • Published Date: Jul 14, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing prevalence of blood-related disease and the increasing geriatric population is estimated to boost the market growth.

The market is anticipated to attain a CAGR of ~4% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Sysmex Corporation, Haemochrom Diagnostics GmbH, Eurobio Scientific, LABiTec Labor BioMedical Technologies GmbH, Thermo Fisher Scientific Inc., Terumo Corporation, and others.

The market size of the blood platelets market was USD 5.2 Billion in the year 2022.

The platelet count ranges from 150,000 to 450,000 platelets normally per microliter of blood.
Blood Platelets Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying